Psychedelic Therapy in Society: 2019 International Forum on Consciousness Explores Transformative Potential of Psychedelics in Mental Health Treatment


Researchers and thought leaders who investigate the potential of psychedelic therapies, including Dr. Robin Carhart-Harris, Head of Psychedelic Research at Imperial College London, will engage in a compelling exploration of Psychedelic Therapy in Society: Exploring the Mechanisms of Action and Delivery of Care at the 18th International Forum on Consciousness May 16-17, 2019, in Madison, WI.

The latest research in psychedelic therapy suggests the potential for a paradigm shift in how we approach treatment of depression, anxiety and certain forms of mental anguish. Academic research shows that a single dose in combination with preparation and follow-up could have an impact long after the substance has left the body. Questions remain around what exactly happens in the brain that facilitates such a transformation and how treatment of this nature can scale to meet dramatic need.

Find abstracts, schedules, speaker information and more at

  • What: 2019 International Forum on Consciousness “ Psychedelic Therapy in Society: Exploring the Mechanisms of Action and Delivery of Care
  • When: May 16-17, 2019
  • Where: The BioPharmaceutical Technology Center on the Promega Campus, 5445 East Cheryl Parkway, Fitchburg, WI 53711
  • Who: Open to the general public, but limited to 300 participants
  • Registration: Pre-registration is required. Click here or visit

The International Forum on Consciousness is a yearly event dedicated to information-sharing and discussion regarding importantand often challengingtopics related to the exploration of consciousness. It is co-hosted by the BioPharmaceutical Technology Center Institute (BTC Institute) and Promega Corporation. View videos of previous Forums here.

2019 Presenters:

  • Heidi L. Allen, Ph.D., Associate Professor, School of Social Work, Columbia University, New York, NY
  • Robin L. Carhart-Harris, Ph.D., Head of Psychedelic Research, Centre for Neuropsychopharmacology, Division of Brain Sciences, Faulty of Medicine, Imperial College London, London, United Kingdom
  • Tania de Jong, AM, Singer, Speaker, Social Entrepreneur; Founder Mind Medicine Australia, Creative Universe, Creative Innovation Global and Creativity Australia, South Melbourne, Victoria, Australia
  • Adam Halberstadt, Ph.D., Assistant Adjunct Professor, Department of Psychiatry, University of California San Diego, La Jolla, CA
  • Jack Henningfield, Ph.D., Vice President, Research, Health Policy and Abuse Liability, Pinney Associates, Bethesda, MD & Professor, Adjunct, Department of Psychiatry and Behavioral Sciences, The Johns Hopkins University School of Medicine, Baltimore, MD.
  • John D. McCorvy, Ph.D., Assistant Professor, Cell Biology, Neurobiology & Anatomy, Medical College of Wisconsin, Milwaukee, WI
  • Stevens Rehen, Ph.D., Chief of Scientific Programs and Outreach, DOr Research and Education Institute (IDOR); Full Professor, Biomedical Sciences Institute, Universidad e Federal do Rio de Janeiro, Rio de Janeiro, Brazil
  • Will Siu, M.D., DPhil, Psychiatrist, New York, NY
  • Craig A. Vercruysse, MBA, Partner, Moss Adams, San Francisco Bay Area, CA
  • Bennet A. Zelner, Ph.D., Associate Professor, Robert H. Smith School of Business. University of Maryland, College Park, MD

About the BTC Institute

The BTC Institute is a not-for-profit organization operated exclusively for educational, scientific and cultural purposes. Learn more about its K“12 programs, scientific course offerings, and annual educational forums and symposia at

Karin Borgh, (608) 277-2508
[email protected]